Crystalens Results at the Bascom Palmer Eye Institute
Laser in Situ Keratomileusis (LASIK) using the Zeiss VisuMax- MEL80 Platform for the Correction of Myopia Victoria S. Chang, BS Richard M. Awdeh, MD Takeshi Ide, MD, PhD William W. Culbertson, MD Sonia H. Yoo, MD Bascom Palmer Eye Institute, Miami, FL *The first author has no financial or proprietary interest in any materials or methods described herein. WWC and SHY Y have received speaker's honoraria from Carl Zeiss Meditec. VisuMax Femtosecond System 10 ^-15s optical pulse (ultra-short pulse duration)
zone of collateral damage Spherical corneal interface: IOP elevation No vision loss during suction Internal fixation target Auto centration during docking surgeon choice in flap parameters Submicron tissue disruption 0.2 uJ Repetition rate 200kHz Precise focusing 1.0 um 2
MEL 80 Excimer Laser Fast Ablation and Eye Tracker 250 Hz repetition rate Automatic lock on pupil center Additional limbus tracking Corrects for asymmetrical pupil shift Gaussian
beam 0.7mm Optimized beam fluence/shot distribution pattern Additional peripheral pulses based on corneal curvature and RX 3 Purpose To report the visual acuity outcomes, predictability, and safety of the Zeiss VisuMax-MEL80 platform for the treatment of myopia.
4 Methods Retrospective review of initial series of 46 eyes of 26 patients treated for myopia using the Zeiss Visumax-MEL80 platform All eyes had a treatment goal of emmetropia. All data was analyzed using JMP (SAS, Cary, NC) and SPSS (SPSS Inc, Chicago, Illinois) All Snellen visual acuities were converted to a logMAR scale based on a logMAR conversion table Individual letter adjustments where accounted for as 0.02 logMAR per letter.
A Snellen acuity was rounded down one Snellen line if the logMAR score was >0.04 for that respective line. LogMAR scores were converted back to Snellen fractions for the purposes of categorizing the results 5 Demographics Patient Characteristics Age mean (SD) All Patients (N=46) 33.13 (8.97) Female N (%)
25 (54.3) Preoperative UCVA mean (range) 1.11 logMAR (0.21 1.34) Preoperative MRSE mean (range) -3.97 D (-0.875- -6.75) Time to post-operative month one visit 43.8 days( 28 90)
POD 1 UCVA 73.9% of eyes had UCVA of 20/20 or better 91.3% of eyes had UCVA of 20/25 or better POM 1 UCVA -0.029 logMAR (SD: 0.09, Range: -0.18 0.28) 87.0% had UCVA of 20/20 or better 97.9% of eyes had UCVA of 20/25 or better
POM 1 BCVA -0.0726 (SD: 0.078; Range: -0.3 0.04) 100% of eyes had BCVA of 20/20 or better 8 Pre-op and Post-op UCVA 9 POM 1 MRSE 89.1% of eyes were within +/- 0.50 D of emmetropia 97.8% were within +/- 1.00 D of emmetropia
10 POM 1 Attempted vs. Achieved SE r2 = 0.945 11 Conclusion Our results show that LASIK using the VisuMax- MEL80 platform is effective, predictable, and safe in the treatment of myopia. References
Holladay JT. Visual acuity measurements. measurements. J Cataract Refract Surg 2004; 30(2): 287- 90. Shen N, Schaffer CB, Datta D, Mazur E. Surface and bulk photodisruption in turbid tissue using femtosecond laser pulses. Dept. of Physics. Harvard University. 12
Fio, fieri, factus sum postati, nastati, dogoditi se osnovno: fio, fieri, factus sum - nepravilan glagol pasiv glagola facio 3. (facere) feci, factum, "napraviti, činiti, raditi" Služba riječi u rečenici kao i sum, esse, fui , fio tvori imenske predikate...
https://longbaonguyen.github.io Java What do Minecraft, Android phones, and Netflix have in common? They're all programmed in Java! Many of the apps you use in an Android phone or tablet are also written in Java. Netflix uses Java for some of...
Game Logic Project 3 Due date: Tuesday, February 14th Introduction Third in a series of related projects Will build towards working game Focuses on Development of game objects Game logic Using Game Maker Motivation At core of game are the...
Active Shooter on Campus * * * * * * * * * * * Training Objectives Define various shooting situations List measures that can be employed to reduce the effectiveness of an active shooter Describe actions that can be...
29 therapists using SCORE in a research network. 40% had not used any outcome measure before using SCORE. There was some concern about the effect using SCORE might have on the therapy; generally it took about 4 times using it...